| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |